Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.31B
Enterprise Value4.35B
P/E Ratio365.22
PEG Ratio-6.16
Price/Sales Ratio10.03
Price/Book Ratio3.05
Enterprise/Revenue10.16
Enterprise/EBITDA47.08

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin-0.01
AD

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue263.23M
Revenue/Share0.67
Gross Profit168.42M
EBITDA69.66M
Net Income13.74M
Diluted EPS0.03

Balance Sheet

Total Cash599.66M
Total Cash/Share1.48
Total Debt447.51M
Total Debt/Equity0.5
Current Ratio7.29
Book Value Per Share2.22

Price History

52-Week Change-47.91
52-Week High14.15
52-Week Low5.55
Moving Average 50 Days6.28
Moving Average 200 Days8.34

Statistics

Average Volume7.63M
Shares Outstanding405.08M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.02
Trailing Annual Dividend Yield0.37
Payout Ratio1.71
Last Split FactorN/A
Last Split DateN/A
AD